Nephron Pharmaceuticals Corporation

Private

West Columbia, South CarolinaHealthcare & Life Scienceshttps://nephronpharm.com/

Last Round

Debt

Jan 10, 2025

Total Funding Raised

$980M

Momentum

Quiet

No recent growth signals

Company Overview

Nephron Pharmaceuticals Corporation is a pharmaceutical company that manufactures generic respiratory medications and provides sterile drug contract manufacturing and 503B outsourcing services.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain, Smart Manufacturing, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

503B outsourcinggeneric pharmaceuticalsdrug shortage supplysterile compoundingblow-fill-sealpharmaceutical manufacturerprefilled syringescontract manufacturingCDMOinhalation solutionsgeneric respiratory drugssterile manufacturingBFS technologynitrile glovesmedical devices

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nephron Pharmaceuticals Corporation Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Nephron Pharmaceuticals Corporation Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Debt	Jan 10, 2025
Private Equity	Sep 15, 2023
Debt	Aug 1, 2014

View all Funding Rounds

Key People

Founding team and executive leadership

Bryan Beck

Chief Technology Officer

Executive Team

Nephron Pharmaceuticals Corporation Investors

Notable investors and investment history

Investor	Rounds
WhiteHawk Capital Partners	Debt
Blackrock Capital Investment Advisors, LLC	Private Equity

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Mar 2, 2026
Monthly visitors increased 60% MoM, reaching 14K.
May 4, 2025
Monthly visitors increased 105% MoM, reaching 19.1K.

View all signals

Nephron Pharmaceuticals Corporation Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Nephron Pharmaceuticals Corporation Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nephron Pharmaceuticals Corporation's valuation, stock price, and market status.

Firmographic Details

HeadquartersWest Columbia, South Carolina

Employee Range854

Year Founded1997

Last FundingJan 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.